SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJudges Scientific Regulatory News (JDG)

Share Price Information for Judges Scientific (JDG)

Share Price is delayed by 15 minutes
Get Live Data
4,560.00    110.00 (2.47%)
Bid:
4,530.00
Ask:
4,590.00
Spread: 60.00 (1.325%)
Market Cap: £303.73m
JDG Live PriceLast checked at - London Stock Exchange

Intraday Judges Scientific Share Chart

Total Voting Rights

2 Sep 2022 15:16

RNS Number : 1618Y
Judges Scientific PLC
02 September 2022
 

Press Release

 

 

 

Judges Scientific plc

 

("Judges Scientific")

 

Total Voting Rights

 

Judges Scientific confirms that, as at 1 September 2022, the total issued share capital has increased to 6,356,584 Ordinary shares of 5p each ("Ordinary Share").

There are no Ordinary Shares held in treasury. Each Ordinary Share carries voting rights on the basis of one vote per Ordinary Share. Therefore, the total number of voting rights in Judges Scientific is 6,356,584 Ordinary Shares.

The above figure may be used by shareholders as the denominator for calculations to determine if they have a notifiable interest in Judges Scientific under the Disclosure and Transparency Rules, or if such interest has changed.

- Ends -  

 For further information please contact:

 

 

Judges Scientific plc

David Cicurel, CEO

Brad Ormsby, FD

 

Tel: 020 3829 6970

 

Shore Capital (Nominated Adviser & Broker)

Stephane Auton

Iain Sexton

 

Tel: 020 7408 4090

 

Liberum (Joint Broker)

Edward Mansfield

William Hall

 

Tel: 020 3100 2222

 

 

 

Alma PR (Financial Public Relations)

Sam Modlin

Justine James

Joe Pederzolli 

Tel: 020 3405 0205

judges@almapr.co.uk

 

 

Notes to editors:

Judges Scientific plc (AIM: JDG), is a group focused on acquiring and developing companies in the scientific instrument sector. The Group consists of 19 businesses acquired since it was re-admitted to AIM in 2005.

 

The acquired companies are primarily UK-based with products sold worldwide to a diverse range of markets including: higher education institutions, the scientific communities, manufacturers and regulatory authorities. The UK is a recognised centre of excellence for scientific instruments. The Group companies hold five Queen's Awards for innovation and export.

 

The Group's companies predominantly operate in global niche markets, with long term growth fundamentals and resilient margins.

 

Judges Scientific maintains a policy of selectively acquiring businesses that generate sustainable profits and cash. Shareholder returns are created through the repayment of debt, organic growth and dividends.

 

For further information, please visit www.judges.uk.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TVREALNAEFDAEFA
Date   Source Headline
16th Apr 20257:00 amRNSBoard Change and formation of Executive Committee
8th Apr 202512:35 pmRNSDirector/PDMR Shareholding
7th Apr 20257:00 amRNSDirector/PDMR Shareholding
3rd Apr 20257:00 amRNSConfirmation of Full Year Results
19th Mar 20257:00 amRNSUnaudited Preliminary Results
6th Mar 20254:08 pmRNSDirector/PDMR Shareholding
20th Feb 20257:00 amRNSNotice of Investor Presentation
7th Feb 202510:32 amRNSDirector/PDMR Shareholding
3rd Feb 202511:11 amRNSTotal Voting Rights
24th Jan 20256:23 pmRNSDirector/PDMR Shareholding
24th Jan 20253:24 pmRNSHolding(s) in Company
23rd Jan 20257:00 amRNSGrant of Options
20th Jan 20257:00 amRNSFull Year Trading Statement and Notice of Results
9th Jan 202511:44 amRNSDirector/PDMR Shareholding
3rd Jan 20257:00 amRNSTotal Voting Rights
23rd Dec 20249:39 amRNSBlocklisting Return
20th Dec 20247:00 amRNSBoard Change
6th Dec 20241:07 pmRNSDirector/PDMR Shareholding
4th Dec 20246:09 pmRNSDirector/PDMR Shareholding
18th Nov 20247:00 amRNSTrading Update
12th Nov 20245:09 pmRNSDirector/PDMR Shareholding
6th Nov 20245:03 pmRNSDirector/PDMR Shareholding
31st Oct 20244:12 pmRNSTotal Voting Rights
18th Oct 20242:20 pmRNSDirector/PDMR Shareholding
8th Oct 20247:00 amRNSDirector/PDMR Shareholding
7th Oct 20244:42 pmRNSDirector/PDMR Shareholding
2nd Oct 20249:53 amRNSDirector/PDMR Shareholding
26th Sep 20241:22 pmRNSHolding(s) in Company
26th Sep 202412:31 pmRNSDirector/PDMR Shareholding
25th Sep 20244:59 pmRNSDirector/PDMR Shareholding
19th Sep 20247:00 amRNSInterim Results
6th Sep 20244:26 pmRNSDirector/PDMR Shareholding
2nd Sep 20247:00 amRNSExecutive Director and Board Appointment
29th Aug 20247:00 amRNSGeotek coring contract
21st Aug 20247:00 amRNSNotice of Investor Presentation
15th Aug 20247:00 amRNSAcquisition of Magsputter Limited
8th Aug 20249:21 amRNSDirector/PDMR Shareholding
30th Jul 20242:45 pmRNSDirector/PDMR Shareholding
29th Jul 20244:53 pmRNSDirector/PDMR Shareholding
25th Jul 20247:00 amRNSHalf Year Trading Update and Notice of Results
8th Jul 20244:54 pmRNSDirector/PDMR Shareholding
3rd Jul 20247:00 amRNSAmendment and Extension of Bank Facilities
28th Jun 20247:00 amRNSAcquisition of Rockwash Geodata Ltd
21st Jun 20244:06 pmRNSBlocklisting Return
7th Jun 20244:42 pmRNSDirector/PDMR Shareholding
6th Jun 20245:18 pmRNSDirector/PDMR Shareholding
3rd Jun 20247:00 amRNSTotal Voting Rights
21st May 20245:28 pmRNSResult of AGM and GM
21st May 20247:00 amRNSAGM Statement
10th May 20245:08 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.